Feasibility and toxicity of a modified dose intensive R-CODOX-M/IVAC for HIV-associated Burkitt and atypical Burkitt lymphoma (BL): Preliminary results of a prospective multicenter phase II trial of the AIDS Malignancy Consortium (AMC) Meeting Abstract
| Authors: | Noy, A.; Kaplan, L.; Lee, J. |
| Abstract Title: | Feasibility and toxicity of a modified dose intensive R-CODOX-M/IVAC for HIV-associated Burkitt and atypical Burkitt lymphoma (BL): Preliminary results of a prospective multicenter phase II trial of the AIDS Malignancy Consortium (AMC) |
| Meeting Title: | 51st Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 114 |
| Issue: | 22 |
| Meeting Dates: | 2009 Dec 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2009-11-20 |
| Start Page: | 1415 |
| End Page: | 1416 |
| Language: | English |
| ACCESSION: | WOS:000272725804337 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V114.22.3673.3673 |
| Notes: | Meeting Abstract: 3673 -- Source: Wos |
